JP Morgan Chase’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-24,000
Closed -$165K 6544
2022
Q3
$165K Sell
24,000
-26,000
-52% -$181K ﹤0.01% 5042
2022
Q2
$418K Buy
+50,000
New +$699K ﹤0.01% 4675
2020
Q1
Sell
-300,000
Closed -$8.98M 5304
2019
Q4
$8.98M Hold
300,000
﹤0.01% 2199
2019
Q3
$6.55M Sell
300,000
-50,600
-14% -$1.16M ﹤0.01% 2468
2019
Q2
$8.71M Buy
350,600
+50,600
+17% +$1.2M ﹤0.01% 2208
2019
Q1
$7.41M Sell
300,000
-68,200
-19% -$1.63M ﹤0.01% 2288
2018
Q4
$6.8M Buy
368,200
+143,200
+64% +$3.41M ﹤0.01% 2321
2018
Q3
$5.78M Hold
225,000
﹤0.01% 2623
2018
Q2
$5.23M Sell
225,000
-130,000
-37% -$2.69M ﹤0.01% 2655
2018
Q1
$5.65M Buy
355,000
+5,000
+1% +$93.1K ﹤0.01% 2481
2017
Q4
$7.27M Sell
350,000
-195,000
-36% -$3.09M ﹤0.01% 2376
2017
Q3
$7.5M Buy
545,000
+145,000
+36% +$2.19M ﹤0.01% 2232
2017
Q2
$6.92M Buy
400,000
+300,000
+300% +$3.6M ﹤0.01% 2249
2017
Q1
$1.1M Sell
100,000
-43,900
-31% -$604K ﹤0.01% 3359
2016
Q4
$2.09M Buy
143,900
+8,900
+7% +$163K ﹤0.01% 3048
2016
Q3
$3.31M Hold
135,000
﹤0.01% 2504
2016
Q2
$2.72M Hold
135,000
﹤0.01% 2641
2016
Q1
$3.55M Sell
135,000
-216,000
-62% -$16M ﹤0.01% 2399
2015
Q4
$35.7M Buy
351,000
+315,000
+875% +$35.4M 0.01% 984
2015
Q3
$6.42M Buy
+36,000
New +$8.39M ﹤0.01% 2065
2015
Q2
Sell
-5,986
Closed -$1.19M 4016
2015
Q1
$1.19M Sell
5,986
-394,614
-99% -$70M ﹤0.01% 3141
2014
Q4
$57.3M Buy
400,600
+365,600
+1,045% +$49.2M 0.01% 871
2014
Q3
$4.59M Buy
+35,000
New +$4.17M ﹤0.01% 2417
2014
Q1
Sell
-7,100
Closed -$834K 3598
2013
Q4
$834K Hold
7,100
﹤0.01% 3236
2013
Q3
$740K Hold
7,100
﹤0.01% 3436
2013
Q2
$612K Buy
+7,100
New +$559K ﹤0.01% 3506

Other funds holding BHC

JP Morgan Chase's BHC Position: Q1 2026 in Review

JP Morgan Chase increased its Bausch Health (BHC) stake by 79% in Q1 2026, buying an estimated $1.2M and bringing the position to 453,807 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #4002.

JP Morgan Chase first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.59B in Q3 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • JP Morgan Chase held 453,807 shares of Bausch Health worth $2.28M as of Q1 2026.
  • JP Morgan Chase bought 200,167 Bausch Health shares in Q1 2026, an estimated $1.2M.
  • Bausch Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4002 holding.
  • JP Morgan Chase first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Bausch Health position peaked at $1.59B in Q3 2015.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.